Mitsubishi Tanabe Pharma logo

4508 - Mitsubishi Tanabe Pharma Share Price

¥2006 0.0  0.0%

Last Trade - 26/02/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £2.89bn
Position in Universe th / 3867
Bullish
Bearish
Unlock 4508 Revenue
Momentum
Relative Strength (%)
1m -5.46%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
412,675 415,124 425,764 423,977 433,855 424,767 377,000 367,800 +0.6%
-5.4 +8.8 +19.1 +8.1 -15.9 -37.6 -84.8 +299.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2019, Mitsubishi Tanabe Pharma Corp revenues decreased 11% to Y297.41B. Net income decreased 56% to Y18.22B. Revenues reflect Domestic Ethical Drug segment decrease of 66% to Y78.15B, Royalty Incomes segment decrease of 91% to Y5.05B, Japan (Country) segment decrease of 66% to Y80.76B, Euro Zone (Region) segment decrease of 94% to Y2.79B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4508 Revenue Unlock 4508 Revenue

Net Income

4508 Net Income Unlock 4508 Revenue

Normalised EPS

4508 Normalised EPS Unlock 4508 Revenue

PE Ratio Range

4508 PE Ratio Range Unlock 4508 Revenue

Dividend Yield Range

4508 Dividend Yield Range Unlock 4508 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4508 EPS Forecasts Unlock 4508 Revenue
Profile Summary

Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The medical supplies business is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Company’s subsidiaries receive raw materials from the company and sell products locally.

Directors
Last Annual March 31st, 2019
Last Interim December 31st, 2019
Incorporated December 13, 1933
Public Since May 16, 1949
No. of Shareholders: 25,991
No. of Employees: 7,228
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Tokyo Stock Exchange
Shares in Issue 560,784,221
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4508 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4508
Upcoming Events for 4508
Frequently Asked Questions for Mitsubishi Tanabe Pharma
What is the Mitsubishi Tanabe Pharma share price?

As of 26/02/20, shares in Mitsubishi Tanabe Pharma are trading at ¥2006, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Mitsubishi Tanabe Pharma share price performed this year?

Shares in Mitsubishi Tanabe Pharma are currently trading at ¥2006 and the price has moved by 28.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Mitsubishi Tanabe Pharma price has moved by 21.77% over the past year.

What are the analyst and broker recommendations for Mitsubishi Tanabe Pharma?

Of the analysts with advisory recommendations for Mitsubishi Tanabe Pharma, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Mitsubishi Tanabe Pharma is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Mitsubishi Tanabe Pharma next release its financial results?

Mitsubishi Tanabe Pharma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Mitsubishi Tanabe Pharma dividend yield?

The Mitsubishi Tanabe Pharma dividend yield is % based on the trailing twelve month period.

Does Mitsubishi Tanabe Pharma pay a dividend?

Last year, Mitsubishi Tanabe Pharma paid a total dividend of 56, and it currently has a trailing dividend yield of %. Looking ahead, Mitsubishi Tanabe Pharma has not announced an ex-dividend date yet.

When does Mitsubishi Tanabe Pharma next pay dividends?

Mitsubishi Tanabe Pharma has yet to annouce their ex-dividend date. The historic dividend yield on Mitsubishi Tanabe Pharma shares is currently %.

How do I buy Mitsubishi Tanabe Pharma shares?

To buy shares in Mitsubishi Tanabe Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Mitsubishi Tanabe Pharma?

Shares in Mitsubishi Tanabe Pharma are currently trading at ¥2006, giving the company a market capitalisation of £n/a.

Where are Mitsubishi Tanabe Pharma shares listed? Where are Mitsubishi Tanabe Pharma shares listed?

Here are the trading details for Mitsubishi Tanabe Pharma:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4508
What kind of share is Mitsubishi Tanabe Pharma?

We were not able to load our ranking data for Mitsubishi Tanabe Pharma

Is there a Mitsubishi Tanabe Pharma share price forecast 2020?

We were not able to load any forecast data for Mitsubishi Tanabe Pharma.

How can I tell whether the Mitsubishi Tanabe Pharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mitsubishi Tanabe Pharma. Over the past six months, the relative strength of its shares against the market has been 79.36%. At the current price of ¥2006, shares in Mitsubishi Tanabe Pharma are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Mitsubishi Tanabe Pharma PE Ratio?

We were not able to find PE ratio data for Mitsubishi Tanabe Pharma.

Who are the key directors of Mitsubishi Tanabe Pharma?

We were unable to find the directors for Mitsubishi Tanabe Pharma.

Who are the major shareholders of Mitsubishi Tanabe Pharma?

Here are the top five shareholders of Mitsubishi Tanabe Pharma based on the size of their shareholding:

Mitsubishi Chemical Holdings Corp Corporation
Percentage owned: 99.92% (561.0m shares)
Mitsubishi UFJ Trust and Banking Corporation Bank and Trust
Percentage owned: 4.13% (23.2m shares)
Statens Pensjonsfond Utland Mutual Fund
Percentage owned: 0.89% (4.99m shares)
California Public Employees' Retirement System Pension Fund
Percentage owned: 0.34% (1.91m shares)
Nomura Asset Management Co., Ltd. Investment Advisor
Percentage owned: 0.24% (1.38m shares)
Similar to 4508
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.